Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 680

1.

Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.

Keever-Taylor CA, Margolis D, Konings S, Sandford GR, Nicolette CA, Lawendowski C, Burns WH.

Biol Blood Marrow Transplant. 2001;7(5):247-56.

3.

Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers.

Szmania S, Galloway A, Bruorton M, Musk P, Aubert G, Arthur A, Pyle H, Hensel N, Ta N, Lamb L Jr, Dodi T, Madrigal A, Barrett J, Henslee-Downey J, van Rhee F.

Blood. 2001 Aug 1;98(3):505-12.

4.

Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus.

Akiyama Y, Maruyama K, Mochizuki T, Sasaki K, Takaue Y, Yamaguchi K.

Immunol Lett. 2002 Aug 1;83(1):21-30.

PMID:
12057851
5.

Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells.

Forsberg O, Carlsson B, Tötterman TH, Essand M.

Br J Haematol. 2008 Apr;141(2):188-99. doi: 10.1111/j.1365-2141.2008.07026.x. Epub 2008 Feb 26.

PMID:
18307565
7.

Ex vivo stimulation of cytomegalovirus (CMV)-specific T cells using CMV pp65-modified dendritic cells as stimulators.

Carlsson B, Cheng WS, Tötterman TH, Essand M.

Br J Haematol. 2003 May;121(3):428-38.

PMID:
12716365
8.

Characterization of host immunity to cytomegalovirus pp150 (UL32).

La Rosa C, Wang Z, Lacey SF, Markel SF, Sharma MC, Martinez J, Lalimarmo MM, Diamond DJ.

Hum Immunol. 2005 Feb;66(2):116-26.

PMID:
15694996
9.

B lymphoblastoid cell lines as efficient APC to elicit CD8+ T cell responses against a cytomegalovirus antigen.

Sun Q, Burton RL, Dai LJ, Britt WJ, Lucas KG.

J Immunol. 2000 Oct 1;165(7):4105-11.

10.

Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.

Ramadan G, Konings S, Kurup VP, Keever-Taylor CA.

Cytotherapy. 2004;6(3):223-34.

PMID:
15203979
11.
12.

Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.

Heine A, Grünebach F, Holderried T, Appel S, Weck MM, Dörfel D, Sinzger C, Brossart P.

Mol Ther. 2006 Feb;13(2):280-8. Epub 2005 Oct 10.

14.

Induction of CMV-specific T-cell lines using Ag-presenting cells pulsed with CMV protein or peptide.

Einsele H, Rauser G, Grigoleit U, Hebart H, Sinzger C, Riegler S, Jahn G.

Cytotherapy. 2002;4(1):49-54.

PMID:
11953041
15.

Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells.

Arrode G, Boccaccio C, Lulé J, Allart S, Moinard N, Abastado JP, Alam A, Davrinche C.

J Virol. 2000 Nov;74(21):10018-24.

16.

Identification of T cell epitopes by the use of rapidly generated mRNA fragments.

Britten CM, Meyer RG, Graf C, Huber C, Wölfel T.

J Immunol Methods. 2005 Apr;299(1-2):165-75. Epub 2005 Mar 31.

PMID:
15914199
17.

Rapid generation of CMV pp65-specific T cells for immunotherapy.

Bao L, Sun Q, Lucas KG.

J Immunother. 2007 Jul-Aug;30(5):557-61.

PMID:
17589296
18.

Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy.

Trivedi D, Williams RY, O'Reilly RJ, Koehne G.

Blood. 2005 Apr 1;105(7):2793-801. Epub 2004 Oct 28.

19.

Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.

Melenhorst JJ, Solomon SR, Shenoy A, Hensel NF, McCoy JP Jr, Keyvanfar K, Barrett AJ.

J Immunother. 2006 Jul-Aug;29(4):436-43; discussion 365-6.

PMID:
16799339
20.

Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus.

Solache A, Morgan CL, Dodi AI, Morte C, Scott I, Baboonian C, Zal B, Goldman J, Grundy JE, Madrigal JA.

J Immunol. 1999 Nov 15;163(10):5512-8.

Supplemental Content

Support Center